[Possibility of using tumor markers, pituitary gonadotropic hormones and prolactin in the diagnosis of breast cancer].
The levels of gonadotropic hormones, prolactin, carcinoembryonic antigen (CEA) and ferritin were measured in 111 females (52--cancer, 32--benign tumors and 27--healthy controls in menopause). Radioimmunologic study showed a significant increase in prolactin, CEA and ferritin levels in patients with T1-2N0M0 breast tumors.
D001943:Breast Neoplasms / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005260:Female; D005293:Ferritins / Q000097:blood*; D006065:Gonadotropins, Pituitary / Q000097:blood*; D006801:Humans; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*; D011863:Radioimmunoassay
D002272:Carcinoembryonic Antigen; D006065:Gonadotropins, Pituitary; D011388:Prolactin; D005293:Ferritins
O vozmozhnosti ispol'zovaniia opukholevykh markerov, gonadotropnykh gormonov gipofiza i prolaktina v diagnostike raka molochnoĭ zhelezy.